BridgeMD
New treatment option for Well-Being, Psychological
Official title Chinese Poem Writing for Improving Mental Wellbeing
ClinicalTrials.gov ID: NCT06581952
What this study is testing
- What it's testing
- This research proposal aims to explore the impact of poem writing on the well-being of adult volunteers serving patients recovering from mental illness in Hong Kong. The research design was a single-arm intervention study with 30 participants.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Volunteers serving for people recovering from mental illness or other community residents
- Aged 18 years old and above
- Able to understand Cantonese and read Chinese
You likely can't join if
- Physically or mentally unable to communicate
- Unwilling to participate or give consent
- Being involved in other similar activities or research
The study team makes the final eligibility decision.
Where it's taking place
- Hong Kong, Hong Kong
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hong Kong, Hong Kong. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.